Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196 | -3,497 | -2,372 | -787 | -305 |
| Depreciation Amortization | 1 | 617 | 45 | 30 | 15 |
| Accounts payable and accrued liabilities | 0 | -80 | -108 | -89 | -52 |
| Other Working Capital | -8 | -91 | -100 | -72 | -48 |
| Other Operating Activity | 95 | 2,736 | 2,252 | 698 | 309 |
| Operating Cash Flow | $-108 | $-314 | $-283 | $-220 | $-82 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -2 | -2 | N/A |
| Investing Cash Flow | $N/A | $-3 | $-2 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2 | N/A | 20 | 9 | 3 |
| Debt Issued | 50 | 198 | 131 | 131 | 82 |
| Common Stock Issued | N/A | 104 | 104 | 104 | 79 |
| Other Financing Activity | 14 | 22 | 0 | 0 | 0 |
| Financing Cash Flow | $66 | $325 | $255 | $244 | $164 |
| Exchange Rate Effect | 2 | 0 | 1 | 1 | -10 |
| Beginning Cash Position | 58 | 51 | 51 | 51 | 51 |
| End Cash Position | 17 | 58 | 22 | 74 | 123 |
| Net Cash Flow | $-42 | $7 | $-30 | $23 | $83 |
| Free Cash Flow | |||||
| Operating Cash Flow | -108 | -314 | -283 | -220 | -82 |
| Capital Expenditure | N/A | -3 | -2 | -2 | N/A |
| Free Cash Flow | -108 | -318 | -285 | -222 | -82 |